EUCTR2010-020979-23-IT进行中（未招募）不适用
Randomized fase II study using chemiotherapy with metformine in patients affected by pancreas metastatic cancer. - ND
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR0 个研究点开始时间: 2010年7月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-cytologic and istologic diagnosis of pancreatic adenocarcinoma; -presence of metasatasis; -absebce of crebral metastasis with symptoms; -age between 18-75 yeras old (71-75 only if KPS>70%); -Karnofsky PS > 60 ; -measurable disease; -GB > 3500/mm3, neutrofili > 1500/mm3; Plt > 100000/mm3; Hb > 10 g/dl; -creatinine < 1.5 mg/dL; bilirubine < 2 mg/dL; SGOT e SGPT < 3 UNL; -written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-previous metformine assumption; -previous or concomitant malignant tumors, apart from carcinoma in sito of the uterine cervix and epitelial malignant tumors adeguately treated or other malignant tumors if patiet was free from pathology from almost 5 years ; -pregnancy and breast feeding; -counter-indications for chemiotherapic treatment (acute heart attack 4 months before the study enrollment, heart failure; -alcool abuse;
研究者
相似试验
已完成
2 期
Randomized Phase II Trial On Primary Chemotherapy With High-Dose Methotrexate And High-Dose Cytarabine With Or Without Thiotepa, And With Or Without Rituximab, Followed By Brain Irradiation Vs. High-Dose Chemotherapy Supported By Autologous Stem Cells Transplantation For Immunocompetent Patients With Newly Diagnosed Primary CNS LymphomaCentral Nervous System LymphomaDRKS00003763niversitätsklinikum Freiburg, Abt. Med 1, Hämatologie/ Onkologie227
进行中（未招募）
不适用
A Randomized Phase II Study of two chemotherapy regimens, Pemetrexed-Carboplatin, and Gemcitabine-Vinorelbine, in Anthracycline and Taxane Pretreated Advanced Breast Cancer Patients - NDWomen with histologic or cytologic diagnosis of advanced breast cancer, who have received one prior chemotherapy containing anthracyclines as neo adjuvant or palliative 1st-line treatment and one prior chemotherapy containing taxanes as neo adjuvant or palliative 1st-line treatment.MedDRA version: 8.1Level: LLTClassification code 10055113Term: Breast cancer metastaticEUCTR2006-000441-19-ITELI LILLY160
进行中（未招募）
不适用
Randomised phase II trial on primary chemotherapy with high-dose Methotrexate and high-dose Cytarabine with or without Thiotepa, and with or without Rituximab, followed by brain irradiation vs high-dose chemotherapy supported by autologous stem cells transplantation for immunocompetent patients with newly diagnosed Primary CNS Lymphoma. - IELSG 32EUCTR2009-012432-32-GBniversity Hospital Southampton NHS Foundation Trust126
进行中（未招募）
不适用
Randomized phase II trial on primary chemotherapy with high-dose methotrexate and high-dose cytarabine with or without thiotepa, and with or without rituximab, followed by brain irradiation vs. high-dose chemotherapy supported by autologous stem cells transplantation for immunocompetent patients with newly diagnosed primary cns lymphoma. - IELSG 32newly diagnosed primary CNS lymphoma in immunocompetent patientsMedDRA version: 9.1Level: LLTClassification code 10036685EUCTR2009-012432-32-ITIELSG-International Extranodal Lymphoma Study Group126
进行中（未招募）
不适用
Et randomiseret fase ll studie af primær kemoterapi med højdosis Methotrexat oghøjdosis Cytarabin med eller uden thiotepa og med eller uden Rituximab efterfulgtaf strålebehandling eller højdosis kemoterapi med autolog stamcelletransplantationhos immunkompetente patienter med nydiagnosticeret primært CNS-lymfom.ewly diagnosed Primary CNS LymphomaEUCTR2009-012432-32-DKInternational Extranodal Lymphoma Srudy Group IELSG126